144 related articles for article (PubMed ID: 35904019)
1. Bullous pemphigoid during the treatment of psoriasis vulgaris with risankizumab.
Fukada N; Suzuki T; Aoyama K; Kinjo A; Yamazaki K; Sato T
J Dermatol; 2023 Feb; 50(2):e72-e73. PubMed ID: 35904019
[No Abstract] [Full Text] [Related]
2. A case report of bullous pemphigoid following secukinumab therapy for a patient with psoriasis.
Wang G; Hu X; Han S; Zhou M
J Dermatolog Treat; 2024 Dec; 35(1):2366535. PubMed ID: 38945532
[No Abstract] [Full Text] [Related]
3. Coexistence of psoriasis and bullous pemphigoid: remission with low-dose methotrexate.
Gunay U; Gunduz K; Ermertcan AT; Kandiloğlu AR
Cutan Ocul Toxicol; 2013 Jun; 32(2):168-9. PubMed ID: 22429144
[TBL] [Abstract][Full Text] [Related]
4. Bullous pemphigoid induced by ustekinumab: a case report.
Marin M; Alzueta N; Castresana M; Gascón A; Pío M
Eur J Hosp Pharm; 2021 Jan; 28(1):47-49. PubMed ID: 33355283
[TBL] [Abstract][Full Text] [Related]
5. Ixekizumab successfully treated refractory psoriasis concurrent bullous pemphigoid.
Xiao Y; Gu Y; Xia D; Zhou X; Li W
J Dermatol; 2023 Feb; 50(2):e76-e78. PubMed ID: 36028948
[No Abstract] [Full Text] [Related]
6. Bullous pemphigoid associated with psoriasis: a good response to methotrexate.
Vargas P; Giacaman P; Fernández J; Morales C
An Bras Dermatol; 2019; 94(2):224-226. PubMed ID: 31090831
[TBL] [Abstract][Full Text] [Related]
7. Development of bullous pemphigoid during secukinumab treatment for psoriasis.
Ho PH; Tsai TF
J Dermatol; 2017 Sep; 44(9):e220-e221. PubMed ID: 28543960
[No Abstract] [Full Text] [Related]
8. Two cases with bullous pemphigoid relapsed after using interleukin-17A inhibitors for psoriasis: A paradoxical reaction.
Wang R; Wang A; Wang M
J Dermatol; 2023 Jul; 50(7):956-959. PubMed ID: 36880309
[TBL] [Abstract][Full Text] [Related]
9. Efalizumab-induced bullous pemphigoid.
Duong TA; Buffard V; André C; Ortonne N; Revuz J; Bagot M; Roujeau JC
J Am Acad Dermatol; 2010 Jan; 62(1):161-162. PubMed ID: 20082902
[No Abstract] [Full Text] [Related]
10. A successful treatment with ustekinumab in a case of relapsing bullous pemphigoid associated with psoriasis.
Loget J; Plée J; Antonicelli F; Bernard P
J Eur Acad Dermatol Venereol; 2017 May; 31(5):e228-e230. PubMed ID: 27730667
[No Abstract] [Full Text] [Related]
11. Anti-laminin-gamma 1 Pemphigoid with Generalized Pustular Psoriasis and Psoriasis Vulgaris.
Fujimura Y; Natsuga K; Hamade Y; Nomura Y; Kaku Y; Muramatsu R; Shimizu H
Acta Derm Venereol; 2016 Jan; 96(1):120-1. PubMed ID: 26074471
[No Abstract] [Full Text] [Related]
12. Generalized pustular psoriasis complicated with bullous pemphigoid.
Tsuchida Y; Hayashi R; Ansai O; Nakajima M; Oginezawa M; Kawai T; Yokoyama R; Deguchi T; Hama N; Shinkuma S; Abe R
Int J Dermatol; 2019 Mar; 58(3):e66-e67. PubMed ID: 30516289
[No Abstract] [Full Text] [Related]
13. A case of herpetiform pemphigus mimicking bullous pemphigoid after using secukinumab and successfully treated with sulfasalazine.
Wang R; Wang M
J Dermatol; 2023 Dec; 50(12):1625-1628. PubMed ID: 37641883
[TBL] [Abstract][Full Text] [Related]
14. Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid.
Kamata M; Asano Y; Shida R; Maeda N; Yoshizaki A; Miyagaki T; Kawashima T; Tada Y; Sato S
J Dermatol; 2019 Jun; 46(6):e216-e217. PubMed ID: 30628103
[No Abstract] [Full Text] [Related]
15. A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapy.
Saraceno R; Citarella L; Spallone G; Chimenti S
Clin Exp Dermatol; 2008 Mar; 33(2):154-5. PubMed ID: 18021271
[TBL] [Abstract][Full Text] [Related]
16. Guselkumab-associated bullous pemphigoid in a psoriasis patient: A case report and review of the literature.
Burlando M; Capurro N; Herzum A; Cozzani E; Parodi A
Dermatol Ther; 2022 Jan; 35(1):e15207. PubMed ID: 34791777
[TBL] [Abstract][Full Text] [Related]
17. Development of bullous pemphigoid during treatment of psoriasis with adalimumab.
Stausbøl-Grøn B; Deleuran M; Sommer Hansen E; Kragballe K
Clin Exp Dermatol; 2009 Oct; 34(7):e285-6. PubMed ID: 19438555
[No Abstract] [Full Text] [Related]
18. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia.
Maki N; Demitsu T; Umemoto N; Nagashima K; Nakamura T; Kakurai M; Nakamura S; Yamada T; Ishii N; Hashimoto T
J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447
[TBL] [Abstract][Full Text] [Related]
19. Bullous pemphigoid occurring during efalizumab treatment for psoriasis: a paradoxical auto-immune reaction?
Monnier-Murina K; Du Thanh A; Merlet-Albran S; Guillot B; Dereure O
Dermatology; 2009; 219(1):89-90. PubMed ID: 19270438
[No Abstract] [Full Text] [Related]
20. Incidental amelioration of bullous pemphigoid during ixekizumab treatment for psoriasis.
Lu L; Yu Y; Zhang J; Fan X; Qi Y; Lin B
J Dermatol; 2022 Jan; 49(1):e13-e15. PubMed ID: 34633684
[No Abstract] [Full Text] [Related]
[Next] [New Search]
